13D/13G Filings - Evelo Biosciences Inc. (EVLO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-08
10:21 am
Purchase
2021-02-05 13G Evelo Biosciences, Inc.
EVLO
FMR CORP 340,168
14.729%
178,047increase
(+109.82%)
Filing
History
2021-02-04
5:30 pm
Purchase
2021-02-02 13D Evelo Biosciences, Inc.
EVLO
Flagship Ventures Fund V, L.P. 1,151,503
43.900%
5,716increase
(+0.50%)
Filing
History
2020-07-01
5:04 pm
Purchase
2020-06-29 13D Evelo Biosciences, Inc.
EVLO
Flagship Ventures Fund V, L.P. 1,145,788
49.700%
234,118increase
(+25.68%)
Filing
History
Goto Prev, 0, 1